We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-12.76%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$595M
AUM Growth
-$43.1M
Cap. Flow
+$44.1M
Cap. Flow %
7.42%
Top 10 Hldgs %
60.6%
Holding
37
New
6
Increased
11
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$21.9M
2
CVS icon
CVS Health
CVS
+$19.9M
3
CELG
Celgene Corp
CELG
+$19.4M
4
QGEN icon
Qiagen
QGEN
+$14.3M
5
AGN
Allergan plc
AGN
+$11.5M

Top Sells

Rank Stock Value
1
IART icon
Integra LifeSciences
IART
+$22.3M
2
MRK icon
Merck
MRK
+$20M
3
BAX icon
Baxter International
BAX
+$14.6M
4
SHPG
Shire pic
SHPG
+$13.9M
5
AZN icon
AstraZeneca
AZN
+$7.24M

Sector Composition

Rank Sector Weight
1 Healthcare 99.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
26
DELISTED
Clovis Oncology, Inc.
CLVS
$6.03M 1.01%
335,577
+150,000
+81% +$3.06M
LXRX icon
27
Lexicon Pharmaceuticals
LXRX
$1.03B
$5.73M 0.96%
862,602
– –
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.56M 0.93%
284,701
+15,000
+6% +$308K
THC icon
29
Tenet Healthcare
THC
$16.7B
$4.6M 0.77%
+268,388
New +$6.5M
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$36.4B
$4.33M 0.73%
59,437
+14,000
+31% +$1.08M
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
$3.43M 0.58%
240,522
-93,578
-28% -$1.42M
SGMO
32
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.78M 0.3%
154,960
– –
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.81B
$348K 0.06%
8,000
-21,368
-73% -$1.17M
AZN icon
34
AstraZeneca
AZN
$255B
– –
-91,453
Closed -$7.24M
IART icon
35
Integra LifeSciences
IART
$1.47B
– –
-338,733
Closed -$22.3M
LLY icon
36
Eli Lilly
LLY
$1.02T
– –
-13,650
Closed -$1.47M
ONCE
37
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-33,814
Closed -$1.84M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2018 Portfolio in Review

As of Q4 2018, Sector Gamma AS held 37 positions worth $595M, down 6.8% from $638M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sector Gamma AS deployed $44.1M of net new capital in Q4 2018, opening 6 new positions and adding to 11 existing holdings. Its largest new stake was CVS Health: 266,670 shares worth $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was Merck, an estimated $20M trimmed.

  • Sector Gamma AS's largest Q4 2018 buy was CVS Health: 266,670 shares worth $17.5M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q4 2018, an estimated $21.9M increase.
  • Sector Gamma AS's biggest Q4 2018 reduction was Merck, cutting an estimated $20M.
  • Sector Gamma AS fully exited Integra LifeSciences in Q4 2018, selling an estimated $22.3M.
  • Sector Gamma AS's ten largest holdings make up 61% of its $595M portfolio in Q4 2018.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q4 2018.
  • Sector Gamma AS's portfolio value fell 6.8% quarter-over-quarter to $595M.

Based on Sector Gamma AS's 13F filing for Q4 2018, filed 12 Feb 2019.